Enoxaparin Sodium Injection
Product Images NDC 68001-633

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 68001-633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Eno0f 0001 01)

An instructional illustration showing two hands holding parts of a syringe, demonstrating how to remove the cap from the needle by pulling the two parts apart, indicated by arrows pointing away from each other.*

FDA Label Image

Figure B (Eno0f 0001 02)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin, indicated by an arrow pointing towards the injection site. The image demonstrates the technique for injecting Enoxaparin Sodium subcutaneously.*

FDA Label Image

Figure C (Eno0f 0001 03)

Illustration showing a hand administering a subcutaneous injection using a syringe pen, with an arrow indicating the direction of injection into the skin. This image is associated with Enoxaparin Sodium injection by BluePoint Laboratories.*

FDA Label Image

Figure D (Eno0f 0001 04)

An instructional illustration showing a hand holding an injection syringe with an arrow indicating the direction to pull or twist the plunger. This image likely demonstrates how to prepare or use the Enoxaparin Sodium injection.*

FDA Label Image

Figure E (Eno0f 0001 05)

Illustration showing a gloved hand disposing of a used syringe into a container labeled with a biohazard symbol. An arrow indicates dropping the syringe into the container, demonstrating safe disposal of injection materials.*

FDA Label Image

Figure (Eno0f 0001 06)

Chemical structure of Enoxaparin Sodium, showing its repeating sugar units with variable substituents R1 and R2, where R1 is either H or SO3Na, and R2 is either SO3Na or COCH3.*

FDA Label Image

Figure (Eno0f 0001 07)

Chemical structure diagram of the active ingredient Enoxaparin Sodium, showing its molecular connections and functional groups as depicted in the image.*

FDA Label Image

Figure 1 (Eno0f 0001 08)

A forest plot chart comparing relative risk between Enoxaparin Sodium (Enox) and Unfractionated Heparin (UFH) across various patient subgroups. The chart includes subgroup categories such as sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI within 30 days, with corresponding patient numbers. The plot visually represents the relative risk estimates favoring Enoxaparin, with numerical risk percentages for each treatment and reduction in risk values.*

FDA Label Image

Figure 2 (Eno0f 0001 09)

A line graph showing the hazard distribution function over time in days to death or myocardial re-infarction, comparing Enoxaparin Sodium and UFH treatments. Two curves represent Enoxaparin and UFH, with Enoxaparin showing a lower hazard distribution. The graph includes a log-rank test p-value <0.0001 and a smaller inset graph depicting data at 1 year with p=0.0111. The number at risk for each treatment group is listed below the time axis.*

FDA Label Image

Label- Enoxaparin Sodium Injection Usp 30 mg (Eno0f 0001 10 V1)

Label for Enoxaparin Sodium Injection USP, 30 mg per 0.3 mL, a subcutaneous injection. The label includes NDC 68001-633-43, highlights a single-dose prefilled syringe, and notes it is Rx Only. Manufacturer information includes BluePoint Laboratories. The label features dosing instructions and warnings in small print alongside a barcode, lot, and expiration date fields.*

FDA Label Image

Carton- Enoxaparin Sodium Injection Usp 30 mg (Eno0f 0001 11 V2)

Packaging label for Enoxaparin Sodium Injection USP, 30 mg per 0.3 mL strength, for subcutaneous use. The label features dosing information, manufacturer BluePoint Laboratories, and indicates the product comes in 10 single-dose prefilled syringes with an automatic safety device. Storage and warning instructions are included.*

FDA Label Image

Label- Enoxaparin Sodium Injection Usp 40 mg (Eno0f 0001 12 V1)

Enoxaparin Sodium Injection, USP label for a subcutaneous injection with a strength of 40 mg per 0.4 mL. The label indicates it is a single-dose prefilled syringe with an automatic safety device, for human prescription use only, labeled by BluePoint Laboratories. The barcode, NDC 68001-634-43, and storage instructions are also visible.*

FDA Label Image

Carton- Enoxaparin Sodium Injection Usp 40 mg (Eno0f 0001 13 V2)

Packaging label for Enoxaparin Sodium Injection, USP, 40 mg per 0.4 mL. The label indicates the product is for subcutaneous use and supplied as 10 single-dose prefilled syringes with an automatic safety device. The labeler is BluePoint Laboratories. The storage instructions and warnings are also visible.*

FDA Label Image

Label- Enoxaparin Sodium Injection Usp 60 mg (Eno0f 0001 14 V1)

Label for Enoxaparin Sodium Injection, USP, 60 mg per 0.6 mL, for subcutaneous use. The label includes dosage and usage instructions, warnings, and storage information. The product is a single-dose prefilled syringe containing 60 mg of enoxaparin sodium in 0.6 mL solution. Labeler is BluePoint Laboratories. The label features barcodes and space for lot and expiration dates.*

FDA Label Image

Carton- Enoxaparin Sodium Injection Usp 60 mg (Eno0f 0001 15 V2)

Packaging label for Enoxaparin Sodium Injection, USP 60 mg per 0.6 mL, a subcutaneous injection. The carton indicates it contains 10 single-dose prefilled syringes with automatic safety devices. The product is labeled for Rx use only and manufactured by BluePoint Laboratories. Additional details include storage instructions and absence of preservatives or natural rubber latex in the container closure.*

FDA Label Image

Label- Enoxaparin Sodium Injection Usp 80 mg (Eno0f 0001 16 V1)

Label for Enoxaparin Sodium Injection, USP, showing 80 mg per 0.8 mL dosage strength. The label states it is for subcutaneous use with a single-dose, autoinjector prefilled syringe containing 80 mg enoxaparin sodium. It includes storage instructions, warnings, lot and expiration date fields, and a barcode. The labeler is BluePoint Laboratories.*

FDA Label Image

Carton- Enoxaparin Sodium Injection Usp 80 mg (Eno0f 0001 17 V2)

Packaging label for Enoxaparin Sodium Injection, USP, 80 mg per 0.8 mL prefilled syringes for subcutaneous use. The label shows the brand name Enoxaparin prominently, with dosage strength and route, along with the labeler BluePoint Laboratories. The box contains 10 single-dose prefilled syringes with automatic safety devices.*

FDA Label Image

Label- Enoxaparin Sodium Injection Usp 100 mg (Eno0f 0001 18 V1)

Two identical labels for Enoxaparin Sodium Injection, USP, 100 mg per mL, labeled for subcutaneous injection in a 1 mL single-dose prefilled syringe with an automatic safety device. Labels include NDC 68001-637-43, Rx only, storage and usage instructions, manufacturer details (King Yin Bio-medical Pharmaceutical Co., Ltd), and barcodes. Labels have peel here tabs on the left.*

FDA Label Image

Carton- Enoxaparin Sodium Injection Usp 100 mg (Eno0f 0001 19 V2)

Packaging label for Enoxaparin Sodium Injection, USP 100 mg per mL, for subcutaneous use. The label indicates the product is supplied as 10 x 1 mL single-dose prefilled syringes with an automatic safety device. Manufactured by BluePoint Laboratories, the label includes storage instructions and warnings, emphasizing that the container closure is not made with natural rubber latex.*

FDA Label Image

Label- Enoxaparin Sodium Injection Usp 120 mg (Eno0f 0001 20 V1)

Label for Enoxaparin Sodium Injection, USP showing a single-dose prefilled syringe with 120 mg per 0.8 mL strength. The label indicates subcutaneous use, includes NDC 68001-638-43, and notes Rx Only status. Manufacturer is BluePoint Laboratories. The label features dosing, storage, and safety information alongside barcodes and peelable sections for vial access.*

FDA Label Image

Carton- Enoxaparin Sodium Injection Usp 120 mg (Eno0f 0001 21 V2)

Carton label for Enoxaparin Sodium Injection, USP, 120 mg per 0.8 mL, for subcutaneous use. The product is supplied as 10 single-dose prefilled syringes with automatic safety devices. Labeler is BluePoint Laboratories. The label includes storage instructions, warnings, and identifies the injection as sterile and preservative-free.*

FDA Label Image

Label- Enoxaparin Sodium Injection Usp 150 mg (Eno0f 0001 22 V1)

Label for Enoxaparin Sodium Injection, USP 150 mg per mL, a single-dose prefilled syringe for subcutaneous use. The label includes dosing information, storage instructions, warnings, and manufacturer details for BluePoint Laboratories. The product is Rx only with an NDC of 68001-639-43.*

FDA Label Image

Carton- Enoxaparin Sodium Injection Usp 150 mg (Eno0f 0001 23 V2)

Packaging label for Enoxaparin Sodium Injection, USP 150 mg per mL from BluePoint Laboratories. The label indicates a 10 x 1 mL single-dose prefilled syringe pack with automatic safety device, intended for subcutaneous use. The label includes storage instructions, warnings, and manufacturer information from Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.*

FDA Label Image

Figure A (Enox Ifu A)

An instructional illustration showing components related to Enoxaparin Sodium injection. It includes a prefilled syringe labeled for Enoxaparin Sodium, a sharp disposal container, an alcohol wipe packet, a small adhesive bandage, and a cotton ball or gauze. Each item is labeled to guide proper usage and disposal.*

FDA Label Image

Figure B (Enox Ifu B)

An instructional illustration showing a pair of hands opening a protective plastic blister to access a prefilled syringe. The image demonstrates how to peel back the foil cover from the blister packaging containing a syringe, intended for subcutaneous injection.*

FDA Label Image

Figure C (Enox Ifu C)

Illustration of a prefilled syringe for subcutaneous injection labeled with an expiration date marker. The syringe includes a protective cap on the needle end and a plunger on the opposite end, designed for administering Enoxaparin Sodium injection.*

FDA Label Image

Figure D (Enox Ifu D)

An instructional diagram of a prefilled syringe labeled with a clear liquid inside. The syringe features a plunger on one end and a cap on the needle end, with a label indicating the liquid as "Clear Liquid." The image illustrates the syringe components and the medication's physical state.*

FDA Label Image

Figure E (Enox Ifu E)

An instructional medical illustration showing a torso with indications for subcutaneous abdominal injection sites on both sides of the navel. The diagram depicts proper areas for administering subcutaneous injections such as Enoxaparin Sodium injection.*

FDA Label Image

Figure F (Enox Ifu F)

An instructional illustration depicting a person using their hand to locate an injection site on the abdomen, likely demonstrating proper subcutaneous injection technique for Enoxaparin Sodium injection.*

FDA Label Image

Figure G (Enox Ifu G)

An instructional diagram showing two hands preparing a syringe injection. One hand holds the syringe with a needle while the other hand is removing or attaching the cap from the needle, indicated by bidirectional arrows.*

FDA Label Image

Figure H (Enox Ifu H)

An instructional diagram showing a hand holding a syringe labeled for dose setting. The illustration includes an arrow indicating downward pressure on the syringe plunger, with the text 'Set your dose' next to the syringe. This likely explains how to adjust the dose for an injection.*

FDA Label Image

Figure I (Enox Ifu I)

An instructional illustration showing a person pinching the skin around the abdominal area, demonstrating a technique likely related to subcutaneous injection administration.*

FDA Label Image

Figure J (Enox Ifu J)

An instructional illustration showing a person administering a subcutaneous injection of Enoxaparin Sodium into the abdomen at a 90-degree angle, highlighting proper injection technique for the medication.*

FDA Label Image

Figure K (Enox Ifu K)

An instructional illustration showing a person administering a subcutaneous injection in the abdominal area. The image depicts one hand pinching the skin around the belly button while the other hand holds a syringe poised for injection. A directional arrow points toward the injection site.*

FDA Label Image

Figure L (Enox Ifu L)

An instructional illustration showing a person injecting a subcutaneous injection into the abdomen area. The image depicts hand placement and injection technique typical for subcutaneous administration, relevant to Enoxaparin Sodium injection.*

FDA Label Image

Figure M (Enox Ifu M)

Illustration showing a hand holding a prefilled syringe labeled for Enoxaparin Sodium injection. A protective sleeve covers the needle end, with an arrow indicating the direction to click or activate the syringe mechanism.*

FDA Label Image

Figure N (Enox Ifu N)

An instructional diagram showing a hand holding an Enoxaparin Sodium injection syringe near a sharps disposal container. The image labels the Enoxaparin Sodium Injection Syringe, Needle Cap, and Sharps Disposal Container, illustrating safe disposal of the syringe after use.*

FDA Label Image

Parts (Enox Ifu Parts)

An instructional illustration showing a syringe before and after use. The 'Before Use' image labels the plunger rod, needle, and needle cap. The 'After Use' image labels the plunger rod and a protective sleeve covering the needle, demonstrating safety features post-injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.